Designer drugs - A continuing chemical (R)evolution

Neuropharmacology. 2018 May 15;134(Pt A):1-3. doi: 10.1016/j.neuropharm.2018.03.037. Epub 2018 Mar 29.

Authors

Michael A Taffe¹, M Foster Olive²

Affiliations

¹ Department of Neuroscience, SP30-2400, 10550 North Torrey Pines Road, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: mtaffe@scripps.edu.
² Department of Psychology, Arizona State University, 950 S. McAllister Ave, Tempe, AZ 85287, USA. Electronic address: foster.olive@asu.edu.

PMID: 29605651
DOI: 10.1016/j.neuropharm.2018.03.037

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural

MeSH terms

Animals
Designer Drugs / chemistry*
Designer Drugs / metabolism
Drug Design*
Humans
Illicit Drugs* / chemistry

Substances

Designer Drugs
Illicit Drugs

Grants and funding

R01 DA043172/DA/NIDA NIH HHS/United States